TTK HEALTHCARE LIMITED (TTKHLTCARE) financials — quarterly results, P&L, cash flow, balance sheet, shareholding

TTK Healthcare Ltd is a standalone TTK Group company in consumer /OTC brands, animal health, medical devices, condoms/sexual-wellness and ready-to-fry foods. HumanPharma was divested in May 2022;agreements to sell EVA and GoodHome were signed in July 2026.[1][2]

TTKHLTCAREUpdated 7 Sept 2026, 15:28

Ttk Healthcare Limited

Market Cap

₹1,542Cr.

Current Price

₹1,091

High / Low

₹1,255/735

Stock P/E

20.2

Book Value₹789
Dividend Yield0.88%
ROCE8.04%
ROE6.30%
Face Value₹10.0

About

TTK Healthcare Ltd is a standalone TTK Group company in consumer /OTC brands, animal health, medical devices, condoms/sexual-wellness and ready-to-fry foods. HumanPharma was divested in May 2022;agreements to sell EVA and GoodHome were signed in July 2026.[1][2]

Quarterly results

Last reported quarters₹ Cr.

Profit & loss

Annual statement₹ Cr.

Shareholding pattern

As of Jun 2026%

Shareholding trend

Ownership over time%

Balance sheet

Assets & liabilities₹ Cr.

Cash flows

Operating, investing & financing₹ Cr.

Key ratios

Historical financial ratios
CategoryMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days343324354743463346424147
Inventory Days62666580771011231028910510798
Days Payable505310013010112117013411611010683
Cash Conversion Cycle4646-11-162223-2119364363
Working Capital Days-31-38-24-30-6-3-32-2844948161
ROCE %20%23%18%15%15%8%6%8%10%9%9%8%

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 7 September 2026 at 15:28


Designed & Shipped by Harshit Bansal